Cardiff Oncology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.6 | $0.7 | $0.5 | $0.4 | $0.4 |
| Operating income | -$49.0 | -$48.7 | -$45.4 | -$39.9 | -$28.9 |
| Net income | -$45.9 | -$45.4 | -$41.4 | -$38.7 | -$28.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$38.0 | -$37.8 | -$31.5 | -$34.8 | -$23.2 |
Shares outstanding 77.8M · Free float 89.0%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.